ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank74
3Y CAGR-26.4%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-26.4%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.39% |
| Q3 2025 | 10.36% |
| Q2 2025 | -21.10% |
| Q1 2025 | 17.31% |
| Q4 2024 | -5.04% |
| Q3 2024 | -8.14% |
| Q2 2024 | -27.80% |
| Q1 2024 | 11.72% |
| Q4 2023 | -11.19% |
| Q3 2023 | -11.04% |
| Q2 2023 | 4.18% |
| Q1 2023 | -14.86% |
| Q4 2022 | 16.04% |
| Q3 2022 | -22.39% |
| Q2 2022 | 12.40% |
| Q1 2022 | -1.70% |
| Q4 2021 | -23.58% |
| Q3 2021 | 12.29% |
| Q2 2021 | -27.26% |
| Q1 2021 | 41.58% |
| Q4 2020 | -10.61% |
| Q3 2020 | -131.75% |
| Q2 2020 | -24.26% |
| Q1 2020 | -6.20% |
| Q4 2019 | -27.56% |
| Q3 2019 | -9.79% |
| Q2 2019 | 0.83% |
| Q1 2019 | 0.00% |